Overall, understanding the molecular cross-talk between AR signaling in CAFs and prostate cancer cells could pave the way for novel therapeutic approaches to combat drug resistance and metastatic disease in prostate cancer (Figure 2). This evidence concerns the gene AR and prostate cancer.